Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks
Abstract
1. Introduction
2. Blood and Blood Derivatives Transmission
3. Control and Prevention Strategies in Blood Banks
Control and Safety Strategies in Blood Donations in Endemic and Non-Endemic Countries
4. Chemoprophylaxis in Blood Banks
Advanced Methodologies and Novel Compounds for Blood Bank Safety
5. Conclusions and Perspectives
Author Contributions
Funding
Conflicts of Interest
References
- WHO Neglected Tropical Diseases—GLOBAL. Available online: https://www.who.int/health-topics/neglected-tropical-diseases (accessed on 3 October 2023).
- Engels, D.; Zhou, X.-N. Neglected tropical diseases: An effective global response to local poverty-related disease priorities. Infect. Dis. Poverty 2020, 9, 10. [Google Scholar] [CrossRef]
- Hotez, P.J.; Aksoy, S.; Brindley, P.J.; Kamhawi, S. What constitutes a neglected tropical disease? PLoS Neglected Trop. Dis. 2020, 14, e0008001. [Google Scholar] [CrossRef]
- Weld, E.D.; Waitt, C.; Barnes, K.; Garcia Bournissen, F. Twice neglected? Neglected diseases in neglected populations. Br. J. Clin. Pharmacol. 2022, 88, 367–373. [Google Scholar] [CrossRef] [PubMed]
- Kropf, S.P.; Lima, N.T. The history of Chagas disease: Reflections on science in action. Memórias Inst. Oswaldo Cruz 2022, 117, e200372. [Google Scholar] [CrossRef]
- Lynn, M.K.; Bossak, B.H.; Sandifer, P.A.; Watson, A.; Nolan, M.S. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020, 205, 105361. [Google Scholar] [CrossRef]
- Chagas Disease—PAHO/WHO|Pan American Health Organization. Available online: https://www.paho.org/en/topics/chagas-disease (accessed on 17 December 2023).
- Chagas, C. Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias Inst. Oswaldo Cruz 1909, 1, 159–218. [Google Scholar] [CrossRef]
- de Sousa, A.S.; Vermeij, D.; Ramos, A.N.; Luquetti, A.O. Chagas disease. Lancet 2024, 403, 203–218. [Google Scholar] [CrossRef]
- Swett, M.C.; Rayes, D.L.; Campos, S.V.; Kumar, R.N. Chagas disease: Epidemiology, diagnosis, and treatment. Curr. Cardiovasc. Rep. 2024, 26, 1105–1112. [Google Scholar] [CrossRef] [PubMed]
- Rassi, A.; Rassi, A.; Marin-Neto, J.A. Chagas disease. Lancet 2010, 375, 1388–1402. [Google Scholar] [CrossRef]
- Bern, C.; Messenger, L.A.; Whitman, J.D.; Maguire, J.H. Chagas disease in the United States: A public health approach. Clin. Microbiol. Rev. 2019, 33, e00023-19. [Google Scholar] [CrossRef] [PubMed]
- Ribeiro, A.L.P.; RAISE Study Collaborators; Machado, Í.; Cousin, E.; Perel, P.; Demacq, C.; Geissbühler, Y.; de Souza, A.; Liprandi, A.S.; Nascimento, B.R.; et al. The burden of Chagas disease in the contemporary world: The RAISE study. Glob. Heart 2024, 19, 2. [Google Scholar] [CrossRef] [PubMed]
- Echavarría, N.G.; Echeverría, L.E.; Stewart, M.; Gallego, C.; Saldarriaga, C. Chagas disease: Chronic Chagas cardiomyopathy. Curr. Probl. Cardiol. 2021, 46, 100507. [Google Scholar] [CrossRef] [PubMed]
- Zuma, A.A.; de Souza, W. Chagas disease chemotherapy: What do we know so far? Curr. Pharm. Des. 2021, 27, 3963–3995. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Molina, J.A.; Crespillo-Andújar, C.; Bosch-Nicolau, P.; Molina, I. Trypanocidal treatment of Chagas disease. Enfermedades Infecc. Microbiol. Clin. (Engl. Ed.) 2021, 39, 458–470. [Google Scholar] [CrossRef] [PubMed]
- Coura, J.R.; Viñas, P.A. Chagas Disease: A new worldwide challenge. Nature 2010, 465, S6–S7. [Google Scholar] [CrossRef] [PubMed]
- Symptoms, Transmission, and Current Treatments for Chagas Disease | DNDi. Available online: https://dndi.org/diseases/chagas/facts (accessed on 3 December 2024).
- Elkheir, N.; Carter, J.; García-Mingo, A.; Chiodini, P. Chagas disease in non-endemic settings. Br. Med. J. 2021, 373, n901. [Google Scholar] [CrossRef] [PubMed]
- Shikanai Yasuda, M.A. Emerging and reemerging forms of Trypanosoma cruzi transmission. Memórias Instuto Oswaldo Cruz 2022, 117, e210033. [Google Scholar] [CrossRef]
- Ullrich, J.; Guertler, L.; Quenzel, E.; Weinauer, F.; Rößler, D.; Kalus, U.; Pruß, A.; Albajar-Viñas, P.; Pritsch, M. Adding a piece to the puzzle of Latin American blood donors and the potential risk of Trypanosoma cruzi transmission in Germany. Front. Cell. Infect. Microbiol. 2022, 12, 1014134. [Google Scholar] [CrossRef]
- Wendel, S. Transfusion transmitted Chagas disease: Is it really under control? Acta Trop. 2010, 115, 28–34. [Google Scholar] [CrossRef]
- Pedreira De Freitas, J.L.; Amato Neto, V.; Sonntag, R.; Biancalana, A.; Nussenzveig, V.; Barreto, J.G. First tests on the accidental transmission of Chagas disease to man by blood transfusion. Rev. Paul. Med. 1952, 40, 36–40. [Google Scholar]
- da Costa, A.C.; Rocha, E.A.; da Silva Filho, J.D.; Fidalgo, A.S.O.d.B.V.; Nunes, F.M.M.; Viana, C.E.M.; Gomes, V.B.A.F.; Oliveira, M.d.F. Prevalence of Trypanosoma cruzi infection in blood donors. Arq. Bras. Cardiol. 2020, 115, 1082–1091. [Google Scholar] [CrossRef]
- Lidani, K.C.F.; Andrade, F.A.; Bavia, L.; Damasceno, F.S.; Beltrame, M.H.; Messias-Reason, I.J.; Sandri, T.L. Chagas disease: From discovery to a worldwide health problem. Front. Public Health 2019, 7, 166. [Google Scholar] [CrossRef]
- Angheben, A.; Boix, L.; Buonfrate, D.; Gobbi, F.; Bisoffi, Z.; Pupella, S.; Gandini, G.; Aprili, G. Chagas disease and transfusion medicine: A perspective from non-endemic countries. Blood Transfus. 2015, 13, 540–550. [Google Scholar] [CrossRef] [PubMed]
- Crowder, L.A.; Wendel, S.; Bloch, E.M.; O’Brien, S.F.; Delage, G.; Sauleda, S.; Leiby, D.A.; WP-TTID Subgroup on Parasites. International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018. Vox Sang. 2022, 117, 58–63. [Google Scholar] [CrossRef]
- Wendel, S. A quimioprofilaxia de doenças transmissíveis por transfusão em componentes lábeis hemoterápicos. Rev. Soc. Bras. Med. Trop. 2002, 35, 275–281. [Google Scholar] [CrossRef] [PubMed]
- Bonametti, A.M.; Castelo Filho, A.; Ramos, L.R.; Baldy, J.L.d.S.; Matsuo, T. Infecção por Trypanosoma cruzi em candidatos a doador de sangue. Rev. Saúde Pública 1998, 32, 566–571. [Google Scholar] [CrossRef] [PubMed]
- González-Guzmán, S.; Paredes-Cervantes, V.; Bagu, E.T.; Crescencio-Trujillo, J.A.; Guerra-Marquez, Á.; Rivas, N.; Alejandre-Aguilar, R.; Bermúdez-Torres, E.; González-Cano, P. Seroprevalence and geographical distribution of sero-positive blood donors to Trypanosoma cruzi at the central blood bank of the national medical center “La Raza”. Transfusion 2019, 59, 639–647. [Google Scholar] [CrossRef]
- Wendel, S.; Gonzaga, A.L. Chagas’ disease and blood transfusion: A new world problem? Vox Sang. 1993, 64, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Martin, D.L.; Goodhew, B.; Czaicki, N.; Foster, K.; Rajbhandary, S.; Hunter, S.; Brubaker, S.A. Trypanosoma cruzi survival following cold storage: Possible implications for tissue banking. PLoS ONE 2014, 9, e95398. [Google Scholar] [CrossRef]
- Cucunubá, Z.M.; Gutiérrez-Romero, S.A.; Ramírez, J.-D.; Velásquez-Ortiz, N.; Ceccarelli, S.; Parra-Henao, G.; Henao-Martínez, A.F.; Rabinovich, J.; Basáñez, M.-G.; Nouvellet, P.; et al. The epidemiology of Chagas disease in the Americas. Lancet Reg. Health Am. 2024, 37, 100881. [Google Scholar] [CrossRef] [PubMed]
- Fernandes, C.D.; Tiecher, F.M.; Balbinot, M.M.; Liarte, D.B.; Scholl, D.; Steindel, M.; Romanha, A. Efficacy of benznidazol treatment for asymptomatic chagasic patients from State of Rio Grande Do Sul evaluated during a three years follow-up. Memórias Inst. Oswaldo Cruz 2009, 104, 27–32. [Google Scholar] [CrossRef] [PubMed]
- Dias, J.C.P.; Ramos, A.N., Jr.; Gontijo, E.D.; Luquetti, A.; Shikanai-Yasuda, M.A.; Coura, J.R.; Torres, R.M.; Melo, J.R.d.C.; de Almeida, E.A.; de Oliveira, W., Jr.; et al. II consenso brasileiro em doença de Chagas, 2015. Epidemiol. Serviços Saúde 2016, 25, 7–86. [Google Scholar] [CrossRef]
- Carrazzone, C.F.V.; de Brito, A.M.; Gomes, Y.M. Importância da avaliação sorológica pré-transfusional em receptores de sangue. Rev. Bras. Hematol. Hemoter. 2004, 26, 93–98. [Google Scholar] [CrossRef]
- Moraes-Souza, H.; Bordin, J.O. Strategies for prevention of transfusion-associated Chagas’ disease. Transfus. Med. Rev. 1996, 10, 161–170. [Google Scholar] [CrossRef]
- Lynn, M.K.; Dye-Braumuller, K.C.; Beatty, N.L.; Dorn, P.L.; Klotz, S.A.; Stramer, S.L.; Townsend, R.L.; Kamel, H.; Vannoy, J.M.; Sadler, P.; et al. Evidence of likely autochthonous Chagas disease in the Southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors. Transfusion 2022, 62, 1808–1817. [Google Scholar] [CrossRef]
- de Andrade, G.N.; Bosch-Nicolau, P.; Nascimento, B.R.; Martins-Melo, F.R.; Perel, P.; Geissbühler, Y.; Demacq, C.; Quijano, M.; Mosser, J.F.; Cousin, E.; et al. Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: An updated systematic review and meta-analysis. Lancet Reg. Health Eur. 2024, 46, 101040. [Google Scholar] [CrossRef] [PubMed]
- Martins-Melo, F.R.; Carneiro, M.; Ribeiro, A.L.P.; Bezerra, J.M.T.; Werneck, G.L. Burden of Chagas disease in Brazil, 1990–2016: Findings from the global burden of disease study 2016. Int. J. Parasitol. 2019, 49, 301–310. [Google Scholar] [CrossRef] [PubMed]
- Bern, C.; Montgomery, S.P.; Katz, L.; Caglioti, S.; Stramer, S.L. Chagas disease and the US blood supply. Curr. Opin. Infect. Dis. 2008, 21, 476–482. [Google Scholar] [CrossRef] [PubMed]
- Forsyth, C.J.; Manne-Goehler, J.; Bern, C.; Whitman, J.; Hochberg, N.S.; Edwards, M.; Marcus, R.; Beatty, N.L.; Castro-Sesquen, Y.E.; Coyle, C.; et al. Recommendations for screening and diagnosis of Chagas disease in the United States. J. Infect. Dis. 2021, 225, 1601–1610. [Google Scholar] [CrossRef] [PubMed]
- Turabelidze, G.; Vasudevan, A.; Rojas-Moreno, C.; Montgomery, S.P.; Baker, M.; Pratt, D.; Enyeart, S. Autochthonous Chagas disease—Missouri, 2018. Morb. Mortal. Wkly. Rep. 2020, 69, 193–195. [Google Scholar] [CrossRef]
- Fearon, M.A.; Scalia, V.; Huang, M.; Dines, I.; Ndao, M.; Lagacé-Wiens, P. A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada. Can. J. Infect. Dis. Med. Microbiol. 2013, 24, 32–34. [Google Scholar] [CrossRef] [PubMed]
- Guggenbühl Noller, J.M.; Froeschl, G.; Eisermann, P.; Jochum, J.; Theuring, S.; Reiter-Owona, I.; Bissinger, A.L.; Hoelscher, M.; Bakuli, A.; von Sonnenburg, F.-J.F.; et al. Describing nearly two decades of Chagas disease in Germany and the lessons learned: A retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000–2018. BMC Infect. Dis. 2020, 20, 919. [Google Scholar] [CrossRef] [PubMed]
- Wirth, M.; Gálvez, R.I.; Jochum, J.; Strauss, R.; Kristensen, K.; Stich, A.; Stegemann, M.; Stahl, P.; Puchner, K.P.; Strasen, J.; et al. Knowledge, attitudes, behaviors, and serological status related to Chagas disease among Latin American migrants in Germany: A cross-sectional study in six German cities. Front. Cell. Infect. Microbiol. 2023, 12, 1047281. [Google Scholar] [CrossRef] [PubMed]
- Cancino-Faure, B.; Fisa, R.; Riera, C.; Bula, I.; Girona-Llobera, E.; Jimenez-Marco, T. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors. Transfusion 2015, 55, 1249–1255. [Google Scholar] [CrossRef] [PubMed]
- Benjamin, R.J.; Stramer, S.L.; Leiby, D.A.; Dodd, R.Y.; Fearon, M.; Castro, E. Trypanosoma cruzi infection in North America and Spain: Evidence in support of transfusion transmission (CME). Transfusion 2012, 52, 1913–1921. [Google Scholar] [CrossRef] [PubMed]
- Nussenzweig, V.; Sonntag, R.; Biancalana, A.; De Freitas, J.L.P.; Amato Neto, V.; Kloetzel, J. Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion. Hospital 1953, 44, 731–744. [Google Scholar] [PubMed]
- Souza, H.M. De Quimioprofilaxia da doença de Chagas transfusional. Realidade atual. Rev. Soc. Bras. Med. Trop. 1989, 22, 1–3. [Google Scholar] [CrossRef] [PubMed]
- Docampo, R.; Moreno, S.N.; Muniz, R.P.; Cruz, F.S.; Mason, R.P. Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet). Science 1983, 220, 1292–1295. [Google Scholar] [CrossRef] [PubMed]
- Rezende, J.; Zupello, W.; Bafutto, M. O problema da transmissão da doença de Chagas por transfusão de sangue. Emprego da violeta de genciana como medida profilática. Rev. Goiana Medicina. 1965, 11, 35–47. [Google Scholar]
- Moraes-Souza, H.; Kerbauy, J.; Barretto, O.C.; Pühler, G.M.; Nonoyama, K.; Juliano, Y. Metabolism and preservation of fresh and stored erythrocytes in blood treated with gentian violet. Braz. J. Med. Biol. Res. 1988, 21, 241–246. [Google Scholar] [PubMed]
- Andrade, J.P.; Marin-Neto, J.A.; Paola, A.a.V.; Vilas-Boas, F.; Oliveira, G.M.M.; Bacal, F.; Bocchi, E.A.; Almeida, D.R.; Fragata Filho, A.A.; Moreira, M.C.V.; et al. I diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica. Arq. Bras. Cardiologia. 2011, 97, 01–48. [Google Scholar] [CrossRef]
- Jimenez-Marco, T.; Cancino-Faure, B.; Girona-Llobera, E.; Alcover, M.M.; Riera, C.; Fisa, R. The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood. Transfusion 2017, 57, 1440–1447. [Google Scholar] [CrossRef] [PubMed]
- Mundt, J.M.; Rouse, L.; Van den Bossche, J.; Goodrich, R.P. Chemical and biological mechanisms of pathogen reduction technologies. Photochem. Photobiol. 2014, 90, 957–964. [Google Scholar] [CrossRef] [PubMed]
- Timm, B.L.; da Gama, A.N.S.; Batista, M.M.; Batista, D.d.G.J.; Boykin, D.W.; De Koning, H.P.; Correia Soeiro, M.d.N. Arylimidamides have potential for chemoprophylaxis against blood-transmitted Chagas disease. Pathogens 2023, 12, 701. [Google Scholar] [CrossRef]
- Guedes-da-Silva, F.; Batista, D.; Meuser, M.; Demarque, K.; Fulco, T.; Araújo, J.; Da Silva, P.; Da Silva, C.F.; Patrick, D.A.; Bakunova, S.M.; et al. In vitro and in vivo trypanosomicidal action of novel arylimidamides against Trypanosoma cruzi. Antimicrob. Agents Chemother. 2016, 60, 2425–2434. [Google Scholar] [CrossRef] [PubMed]
- Pereira, L.Q.; Tanaka, S.C.S.V.; Ferreira-Silva, M.M.; Gomes, F.V.B.A.F.; Santana, M.P.; Aguiar, P.R.; de Araújo Pereira, G.; Gómez-Hernández, C.; Junior, V.R.; De Vito, F.B.; et al. Leukoreduction as a control measure in transfusion transmission of visceral leishmaniasis. Transfusion 2023, 63, 1044–1049. [Google Scholar] [CrossRef] [PubMed]
- Murphy, E.L. Infection with Hhuman T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfus. Clin. Biol. 2016, 23, 13–19. [Google Scholar] [CrossRef]
- Ziemann, M.; Hennig, H. Prevention of transfusion-transmitted cytomegalovirus infections: Which is the optimal strategy? Transfus. Med. Hemotherapy 2013, 41, 40–44. [Google Scholar] [CrossRef] [PubMed]
- Leiby, D.A.; O’Brien, S.F.; Wendel, S.; Nguyen, M.L.; Delage, G.; Devare, S.G.; Hardiman, A.; Nakhasi, H.L.; Sauleda, S.; Bloch, E.M.; et al. International survey on the impact of parasitic infections: Frequency of transmission and current mitigation strategies. Vox Sang. 2019, 114, 17–27. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
da Gama, A.N.S.; Soeiro, M.d.N.C. Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks. Pathogens 2025, 14, 133. https://doi.org/10.3390/pathogens14020133
da Gama ANS, Soeiro MdNC. Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks. Pathogens. 2025; 14(2):133. https://doi.org/10.3390/pathogens14020133
Chicago/Turabian Styleda Gama, Aline Nefertiti Silva, and Maria de Nazaré Correia Soeiro. 2025. "Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks" Pathogens 14, no. 2: 133. https://doi.org/10.3390/pathogens14020133
APA Styleda Gama, A. N. S., & Soeiro, M. d. N. C. (2025). Trypanosoma cruzi Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks. Pathogens, 14(2), 133. https://doi.org/10.3390/pathogens14020133